Shakhobiddinovnа S.S. et al. 2025. Assessment of the Effectiveness of Glp-1 Agonists in Non-Alcoholic Fatty Liver Disease Associated With Obesity and Insulin Resistance. International Journal of Integrative and Modern Medicine. 3, 2 (Feb. 2025), 104–108.